In addition, single nucleotide polymorphisms (SNPs) around the human interleukin 28B (IL28B) gene locus have been reported to affect the efficacy of Peg-IFN and RBV therapy in chronic hepatitis with HCV genotype 1b infection [35,36]. The gene discussed is IFNL3; the disease is chronic hepatitis.